Dirk Bernhardt

Dirk Bernhardt, PhD MBA, currently serves as VP Global Market Access at ITM Isotope Technologies Munich SE since June 2020, focusing on securing market access and reimbursement for novel radiopharmaceuticals and diagnostics in the EU and USA. Prior experience includes roles as Market Access and Commercialisation Counsellor at DiBe Consulting, Senior Director of Market Access and Commercialization at Nanobiotix, and Director of Sales and Marketing at Biolitec Biomedical Technology GmbH, among others. Dirk Bernhardt has established a strong background in market access strategies, commercialization, and product relaunches across various medical sectors. Educational qualifications include a PhD in Microbiology and Immunology from Leibniz Universität Hannover and an MBA in Law and Risk Management from FOM University of Applied Sciences for Economics and Management.